Interventional Innovations Corp.
This article was originally published in Start Up
Executive Summary
Surgical Devices; Restenosis. Interventional Innovations is targeting restenosis with a minimally invasive catheter-based x-ray therapy which uses soft, or less energized x-rays. Interventional's system consists of an x-ray cetheter, a delivery sheathand a control unit that allows the physician to increase the depth of penetration, making it possible to tailor the radiation to treat a variety of disease states.
You may also be interested in...
Restenosis: Multi-Billion-Dollar Market Tempts Many
A variety of approaches are being used to combat the problem of restenosis following angioplasty. In addition to separate drug and device efforts, several companies are working on drug-device collaborations to prevent restenosis.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.